Adaptive Biotechnologies Corp. (ADPT), a commercial-stage biotechnology company, reported a solid start to 2025, with notable financial improvements and growing momentum in its core business segment.
The company operates through two primary businesses: the Minimal Residual Disease (MRD) business and the Immune Medicine (IM) business.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.